Jyong Biotech Ltd.
MENS · Pharmaceutical Preparations
Latest available SEC filing: 20-F ·
Latest disclosures
-
Latest financial period: Q4 2025
Financial facts · Filed
-
Form 20-F
SEC filing · Filed
-
Zhang Wei (Vivi): Form 3
Insider disclosure · Filed · Report period 13 Apr 2026
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- MENS · G83116106 - SHS
Company details and SEC sources
CIK 0001954488 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- MENS on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 23 F 3, No.95, Sec. 1, Xintai 5 Th Rd., Xizhi Dist., New Taipei City
- Incorporated in
- Cayman Islands
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields